Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapses”

2,226 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,226 results

Not applicableStudy completedNCT00724464
What this trial is testing

Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 332
Large-scale testing (Phase 3)Ended earlyNCT01252355
What this trial is testing

Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta

Who this might be right for
Multiple Sclerosis Relapse
Sanofi 534
Not applicableEnded earlyNCT02029963
What this trial is testing

Can Magnetic Brain Stimulation Help Prevent Relapse in Depression?

Who this might be right for
Major Depressive Disorder
University of Manitoba 21
Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Post-approval studies (Phase 4)Study completedNCT01498887
What this trial is testing

Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 347
Early research (Phase 1)Looking for participantsNCT06552416
What this trial is testing

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

Who this might be right for
Acute Myeloid Leukemia, in RelapseMDS
Marker Therapeutics, Inc. 40
Testing effectiveness (Phase 2)UnknownNCT00180947
What this trial is testing

Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

Who this might be right for
RhabdomyosarcomasNeoplasms, Connective and Soft TissueEwing Tumor+3 more
Gustave Roussy, Cancer Campus, Grand Paris 210
Not applicableEnded earlyNCT03483987
What this trial is testing

Re-treatment of HCV Following DAA Failure

Who this might be right for
Chronic Hepatitis C
Sanjay Gandhi Postgraduate Institute of Medical Sciences 18
Early research (Phase 1)Ended earlyNCT02267863
What this trial is testing

APTO-253 in Patients With Relapsed or Refractory AML or MDS

Who this might be right for
Acute Myelogenous Leukemia in RelapseAcute Myelogenous Leukemia, Relapsed, AdultAcute Myelogenous Leukemia, Adult+2 more
Aptose Biosciences Inc. 21
Testing effectiveness (Phase 2)Study completedNCT01305447
What this trial is testing

Getting Physical on Cigarettes - Smoking Cessation & Relapse Prevention

Who this might be right for
Cancer
University of Western Ontario, Canada 413
Not applicableStudy completedNCT02504255
What this trial is testing

Evaluation of Immunological Markers, Inflammatory and Clinical Relapse Psychological Predictive During Crohn's Disease

Who this might be right for
Crohn Disease
Hospices Civils de Lyon 144
Not applicableStudy completedNCT04182178
What this trial is testing

Long-term Follow-up After Surgical Treatment for GERD (Gastroesophageal Reflux Disease)

Who this might be right for
Patient SatisfactionRelapseDysphagia+1 more
Karolinska Institutet 307
Testing effectiveness (Phase 2)UnknownNCT03620032
What this trial is testing

Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses

Who this might be right for
Diffuse Intrinsic Pontine Glioma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT04925193
What this trial is testing

Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in Relapse
University of Colorado, Denver 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05909826
What this trial is testing

Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Dong-A University Hospital 49
Large-scale testing (Phase 3)Looking for participantsNCT06643585
What this trial is testing

Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse

Who this might be right for
Breast Cancer
Prof. Wolfgang Janni 180
Not applicableLooking for participantsNCT00106925
What this trial is testing

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Who this might be right for
Graft-versus-leukemiaGraft vs Host DiseaseGraft Rejection
National Heart, Lung, and Blood Institute (NHLBI) 1,000
Not applicableStudy completedNCT02819349
What this trial is testing

Texting for Relapse Prevention

Who this might be right for
SchizophreniaSchizoaffective Disorder
Center for Innovative Public Health Research 40
Early research (Phase 1)Looking for participantsNCT04881240
What this trial is testing

Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, RefractoryPediatric ALL
St. Jude Children's Research Hospital 60
Early research (Phase 1)Ended earlyNCT02269085
What this trial is testing

Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 8
Load More Results